Maze Therapeutics (MAZE) Interest Coverage Ratio (2024 - 2026)

Maze Therapeutics (MAZE) posted Interest Coverage Ratio of 7.09 for Q1 2026, up 2185.96% sequentially from 0.34 in Q4 2025.

Maze Therapeutics (MAZE) Interest Coverage Ratio (2024 - 2026) Analysis & Trends

Maze Therapeutics has reported Interest Coverage Ratio for 3 years, with the latest figure at 7.09 in Q1 2026.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 7.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 35.78 (changed N/A YoY) and the FY2025 annual result came in at 0.87, down 233.77% from the prior year.
Interest Coverage Ratio advanced to 7.09 in Q1 2026 per MAZE's latest filing, from 0.34 in the prior quarter.
Over five years, Interest Coverage Ratio peaked at 7.09 in Q1 2026 and troughed at 60.17 in Q4 2024.
A 3-year average of 17.81 and a median of 0.34 in 2025 frame the typical range for Interest Coverage Ratio.
The widest YoY moves for Interest Coverage Ratio: up 99.44% in 2025, down 99.44% in 2025.
Over 3 years, Interest Coverage Ratio stood at 60.17 in 2024, then soared by 99.44% to 0.34 in 2025, then soared by 2185.96% to 7.09 in 2026.
According to Business Quant data, Interest Coverage Ratio over the past three periods registered 7.09, 0.34, and 60.17 for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	2.84
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	24.64
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-0.19
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	8.18
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-0.01
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.61
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	2.82
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-0.08
10	Maze Therapeutics	1.51 Bn	1.51 Bn	-	13.27

Download Data